Renal Cancer - Results from #5060

The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition July 25, 2017

Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patients July 24, 2017

Nephrometry scores and perioperative outcomes following robotic partial nephrectomy July 24, 2017

The Effects Of Neoadjuvant Axitinib On Anthropometric Parameters In Patients With Locally Advanced Non-Metastatic Renal Cell Carcinoma July 19, 2017

Renal Medullary Carcinoma: Establishing Standards in Practice July 19, 2017

Immunogenic Chemotherapy Sensitizes Renal Cancer to Immune Checkpoint Blockade Therapy in Preclinical Models July 19, 2017

Axitinib in metastatic renal cell carcinoma: beyond the second-line setting July 17, 2017

Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review July 17, 2017

Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma July 15, 2017

Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma July 14, 2017

[Adverse effects of immune checkpoint inhibitors used to treat melanoma and other cancer] July 14, 2017

Integrating cytokines and angiogenic factors and tumour bulk with selected clinical criteria improves determination of prognosis in advanced renal cell carcinoma July 14, 2017

Clinical predictors of the estimated glomerular filtration rate 1 year after radical nephrectomy in Japanese patients July 13, 2017

Statistical clustering of parametric maps from dynamic contrast enhanced MRI and an associated decision tree model for non-invasive tumour grading of T1b solid clear cell renal cell carcinoma July 13, 2017

Novel immunotherapy in metastatic renal cell carcinoma July 13, 2017

Current Management Options in Metastatic Renal Cell Cancer July 12, 2017

Health-Related Quality of Life as a Prognostic Measure of Clinical Outcomes in Renal Cell Carcinoma: A Review of the CheckMate 025 Trial July 12, 2017

HIF prolyl hydroxylase PHD3 regulates translational machinery and glucose metabolism in clear cell renal cell carcinoma July 12, 2017

Active Surveillance of Nonfatty Renal Masses in Patients With Lymphangioleiomyomatosis: Use of CT Features and Patterns of Growth to Differentiate Angiomyolipoma From Renal Cancer July 11, 2017

A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma July 11, 2017

Page 254 of 456